The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy

NCT04765124 · clinicaltrials.gov ↗

UNKNOWN

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Sponsor

Ahmet Bilici

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]